// App-Quantinova.ai

: Tau and synaptic biomarkers but not amyloid-β are associated with cerebral perfusion in the Alzheimer’s disease spectrum

Researchers

Presenter

  • Khazar Ahmadi

Principal Investigators

  • Joana B Pereira

  • David Berron

  • Jacob W Vogel

  • Silvia Ingala

  • Olof Strandberg

  • Shorena Janelidze

  • Frederik Barkhof

  • Linda Knutsson

  • Danielle van Westen

  • Henri JMM Mutsaerts

  • Sebastian Palmqvist

  • Oskar Hansson

Medical Centers

  • Clinical Memory Research Unit, Department of Clinical Sciences Malmoe, Lund University, Malmoe, Sweden

  • Department of Radiology and Radiological Science, Division of MR Research, The Johns Hopkins University School of Medicine

  • Department of Psychiatry, University of Pennsylvania

  • Department of Anatomy and Neurosciences, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC

  • Lund University,

  • Diagnostic Radiology, Lund University

  • Department of Medical Radiation Physics, Lund University

  • Department of Anatomy and Neurosciences, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC

  • Institutes of Neurology & Healthcare Engineering, University College London

  • Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet

  • Clinical Memory Research Unit, Lund University

  • Memory Clinic, Geneva University Hospitals

  • Department of Neurology, Heidelberg University Hospital

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Mild cognitive impairment

  • Alzheimer's disease

  • Dementia

Biomarkers

  • Amyloid beta 42

  • Cerebrospinal fluid

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A